Health Canada — Medical Devices · Canada · 2020-05-01 · Type III
🏛Compiled from an official source — the facts on this page are reproduced from the issuing authority’s own published notice, which is linked above. No AI-generated text appears on this page. How we use AI →
Reported risk: Between February 4th, 2020 and March 5th 2020, a total of fourteen (14) complaints were received reporting problems with calibration of the Alere NT-proBNP assay resulting in elevation of test results; patient samples, EQA samples and third-party controls.
Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.
ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.